A33 Pill - white oval, 16mm
Pill with imprint A33 is White, Oval and has been identified as Cefuroxime Axetil 250 mg. It is supplied by Aurobindo Pharma Limited.
Cefuroxime is used in the treatment of Bladder Infection; Bacterial Infection; Bone infection; Bronchitis; Epiglottitis and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A33
Cefuroxime Axetil
- Imprint
- A33
- Strength
- 250 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Second generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
hydrogenated cottonseed oil,
microcrystalline cellulose,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0034 (Discontinued) | Aurobindo Pharma Limited |
| 65862-0699 | Aurobindo Pharma Limited |
| 16714-0400 | NorthStar Rx LLC |
| 53002-0275 | Pharmedix (repackager) |
Related images for "A33"
More about cefuroxime
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (149)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: second generation cephalosporins
- Breastfeeding
- En español
Patient resources
- Cefuroxime oral/injection drug information
- Cefuroxime (Injection, Intravenous) (Advanced Reading)
- Cefuroxime (Oral) (Advanced Reading)
- Cefuroxime Tablets
- Cefuroxime Injection
- Cefuroxime Oral Suspension
Other brands
Professional resources
- Cefuroxime monograph
- Cefuroxime Axetil (FDA)
- Cefuroxime Axetil Oral Suspension (FDA)
- Cefuroxime Dextrose (FDA)
- Cefuroxime Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
